Association of FDG PET/CT and immune profiling with pathologic complete response after neoadjuvant immunotherapy in stage II-III non-small cell lung cancer.
- DOI
- 10.21037/tlcr-2026-0628
- Published
- 2026 Aug 31
- Container
- Translational lung cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-2026-0628,
title = {Association of FDG PET/CT and immune profiling with pathologic complete response after neoadjuvant immunotherapy in stage II-III non-small cell lung cancer.},
author = {Lee ES and Park SM and Lee S and Kim S and Choi J and Lee JH and Eo JS and Kim HK and Yong HS and Chen CJ and Robinson H and Dunbar PR and Lee SY},
year = {2026},
journal = {Translational lung cancer research},
doi = {10.21037/tlcr-2026-0628},
url = {https://doi.org/10.21037/tlcr-2026-0628}
}RIS
TY - JOUR TI - Association of FDG PET/CT and immune profiling with pathologic complete response after neoadjuvant immunotherapy in stage II-III non-small cell lung cancer. AU - Lee ES AU - Park SM AU - Lee S AU - Kim S AU - Choi J AU - Lee JH AU - Eo JS AU - Kim HK AU - Yong HS AU - Chen CJ AU - Robinson H AU - Dunbar PR AU - Lee SY PY - 2026 JO - Translational lung cancer research DO - 10.21037/tlcr-2026-0628 UR - https://doi.org/10.21037/tlcr-2026-0628 ER -
APA
ES, L., SM, P., S, L., S, K., J, C., JH, L., JS, E., HK, K., HS, Y., CJ, C., H, R., PR, D., & SY, L. (2026). Association of FDG PET/CT and immune profiling with pathologic complete response after neoadjuvant immunotherapy in stage II-III non-small cell lung cancer.. Translational lung cancer research. https://doi.org/10.21037/tlcr-2026-0628
Source records
- pubmed · retrieved 2026-09-26T00:41:12.534Z